International public awareness of peripheral artery disease
Abstract
Summary:Background: Peripheral artery disease (PAD) of the lower limbs is a common condition with considerable global burden. Some country-specific studies suggest low levels of public awareness. To our knowledge public awareness of PAD has never been assessed simultaneously in several countries worldwide. Patients and methods: This was an international, general public, internet-based quantitative survey assessing vascular health and disease understanding. Questionnaires included 23 closed-ended multiple-choice, Likert scale and binary choice questions. Data were collected from 9,098 survey respondents from nine countries in Europe, North and Latin America during May-June 2018. Results: Overall, familiarity with PAD was low (57% of respondents were “not at all familiar”, and 9% were “moderately” or “very familiar”). Knowledge about PAD health consequences was limited, with 55% of all respondents not being aware of limb consequences of PAD. There were disparities in PAD familiarity levels between countries; highest levels of self-reported awareness were in Germany and Poland where 13% reported to be “very” or “moderately” familiar with PAD, and lowest in Scandinavian countries (5%, 3% and 2% of respondents in Norway, Sweden and Denmark, respectively). There were disparities in awareness according to age. Respondents aged 25–34 were most familiar with PAD, with 12% stating that they were “moderately” or “very” familiar with the condition, whereas those aged 18–24 were the least familiar with PAD (7% “moderately” or “very” familiar with PAD). In the 45–54, 55–64 and 65+ age groups, 9% said they were “moderately” or “very” familiar with the term. There was no important gender-based difference in PAD familiarity. Conclusions: On an international level, public self-reported PAD awareness is low, even though PAD is a common condition with considerable burden. Campaigns to increase PAD awareness are needed to reduce delays in diagnosis and to motivate people to control PAD risk factors.
References
1 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur Heart J.. 2018;39:763–816.
2 . Epidemiology of peripheral artery disease. Circ Res. 2015;116(9):1509–26.
3 Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis. Lancet Glob Health. 2019;7(8):e1020–e30.
4 . Quality and Outcomes Framework (QOF) – 2016–17. 2020 [cited 2020 Dec 21]. Available from: https://digital.nhs.uk/data-and-information/publications/statistical/quality-and-outcomes-framework-achievement-prevalence-and-exceptions-data/quality-and-outcomes-framework-qof-2016-17#summary
5 . Medication adherence and clinical outcomes in dispensing and non-dispensing practices: a cross-sectional analysis. Br J Gen Pract. 2021;71(702):e55–e61.
6 Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization. J Vasc Surg. 2016;64(4):1009–17.e3.
7 . Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1260–344.
8 . Peripheral artery disease: past, present, and future. Am J Med. 2019;132(10):1133–41.
9 . Peripheral artery disease in the lower extremities – prevalence and epidemiology. e-Journal of Cardiology Practice [Internet]. 2018;16(4). [cited 2020 Dec 21]. Available from: https://www.escardio.org/Journals/E-Journal-of-Cardiology-Practice/Volume-16/Peripheral-artery-disease-in-the-lower-extremities-prevalence-and-epidemiology
10 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41(3):407–77.
11 . Knowledge of peripheral artery disease: What do the public, healthcare practitioners, and trainees know? Vasc Med. 2020;25(3):263–73.
12 Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382(9901):1329–40.
13 . Gaps in awareness of peripheral arterial disease in Sri Lanka: a cross sectional study. BMC Public Health. 2016;16(1):1073.
14 . Peripheral artery disease and risk of cardiovascular events in patients with coronary artery disease: insights from the Heart and Soul Study. Vasc Med. 2013;18(4):176–84.
15 . 2020 [cited 2020 Dec 21]. Available from: https://www.eas-society.org/page/PAD.
16 ESVM Guideline on peripheral arterial disease. VASA. 2019;48(Suppl 102):1–79.
17 . Peripheral arterial disease diagnosis and management in primary care: a qualitative study. BJGP Open. 2019;3(3).
18 Atherosclerosis knowledge – diagnosis and management in primary care. VASA. 2018;47(6):465–70.
19 . Internet use, social engagement and health literacy decline during ageing in a longitudinal cohort of older English adults. J Epidemiol Community Health. 2015;69(3):278–83.
20 . Broadband access as a public health issue: the role of law in expanding broadband access and connecting underserved communities for better health outcomes. J Law Med Ethics. 2019;47(2_Suppl):39–42.
21 . The level of knowledge of risk factors for peripheral arterial disease also depends on subjects’ individual clinical situations. Can J Cardiol. 2009;25(9):545.
